Skip to main content
European Commission logo print header

Article Category

Content archived on 2023-04-13

Article available in the following languages:


Working on induced pluripotent stem cells? EBiSC2 wants your opinion

Share your iPSC research needs on services and new iPSC lines and differentiated cell products with the European Bank for induced pluripotent Stem Cells (EBiSC).

Health icon Health

IMI's EBiSC project has established a centralised, not-for-profit human induced pluripotent stem cell (iPSC) bank providing researchers across academia and industry with access to scalable, cost-efficient and consistent, high quality iPSCs for use in research and medicines development. Since its creation in 2014, the bank has grown considerably and now provides a large range of iPSC lines and services to academics, non-profit organisations and companies. Projects generating iPSCs can also make their cell lines sustainable by depositing them in the EBiSC catalogue, ensuring secure long-term storage and simplified access and distribution. The new EBiSC2 project builds on the achievements of the original EBiSC project, including improving its services and providing new iPSC lines and differentiated cell products. To ensure the project continues to offer products and services that are relevant to the scientific community, EBiSC is running a survey. The survey is open until the end of October 2019. - Complete the survey: - Find out more about EBiSC and EBiSC2: